The Government of Australia has announced funding for three medical breakthroughs to aid patients with severe disabilities and chronic back pain in the country.

From the A$500m ($402.6m) Biomedical Translation Fund (BTF) of the National Innovation and Science Agenda, a total of A$13.3m ($10.6m) will be invested towards the new medical initiatives.

Go deeper with GlobalData

Go deeper with GlobalData

The gold standard of business intelligence.

Find out more

Discover B2B Marketing That Performs

Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.

Find out more

Rex Bionics will receive A$5m ($4m) of the total funding to develop a hands-free robotic device for people with the severe inability to walk, exercise and rehabilitate.

The government intends to invest A$3.3m ($2.6m) in Saluda Medical for neuromodulation technology to assist people with debilitating conditions such as chronic back pain.

CHARM Informatics will be provided with A$5m ($4m) for data aggregation and commercialisation services for smart medical device developers.

"This vital funding will support researchers when they need it most."

According to Australian health minister Greg Hunt, BTF acts as a vital funding bridge between the lab and patient to ensure the continuation of biomedical research during translation to market phase.

GlobalData Strategic Intelligence

US Tariffs are shifting - will you react or anticipate?

Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.

By GlobalData

Hunt said: “This vital funding will support researchers when they need it most – for clinical testing, developing prototypes and other requirements before a high-potential product or service can come on the market.

“These new BTF investments reflect the government’s commitment to deliver the benefits of health and medical research to Australian patients.”

Australia Industry, Innovation and Science minister Arthur Sinodinos said that in addition to enhancing biomedical research, BTF helps in creating jobs across the health and medical research sector.

Sinodinos further added: “As well as the BTF, the Turnbull Government is supporting innovation and growth in the sector through the A$20bn ($16bn) Medical Research Future Fund and the research and development tax incentive.”

Medical Device Network Excellence Awards - Nominations Closed

Nominations are now closed for the Medical Device Network Excellence Awards. A big thanks to all the organisations that entered – your response has been outstanding, showcasing exceptional innovation, leadership, and impact

Excellence in Action
HemoSonics has won the 2025 Marketing Award for its impactful promotion of theQuantra Hemostasis System and leadership in blood management education. See how targeted campaigns, thought leadership content, and hands on clinician training are accelerating Quantra’s market traction and shaping the future of hemostasis testing.

Discover the Impact